Latest News Highlights: 15,388 New Coronavirus Cases In India

Mumbai city has reported 1,500 plus new COVID-19 cases for the second day in a row and more than 1,000 cases for the ninth straight day, amid rising concerns. The cases peaked in September-October, after which there was a decline but since mid-February infections have surged again. On Thursday, the city reported 1,508 new coronavirus cases, taking its case tally to 3,38,631, while the death toll in the city reached 11,515 with four more fatalities. As many as 911 patients recovered, taking the number of recoveries to 3,14,257. There are 11,969 active COVID-19 cases in Mumbai now. Thane, Kalyan-Dombivali too continues to report huge cases. Whereas, a week-long lockdown has also been imposed in Nagpur.

New Delhi: 

New cases of coronavirus infection in India were recorded above 15,000 taking the total tally of COVID-19 cases to 1,12,44,786, according to the Union Health Ministry data.

The COVID-19 active caseload is 1,87,462 which now comprises 1.67 per cent of the total infections.

The recovery rate has increased to 96.93 per cent, the data stated.

A total of 15,388 new infections were registered in a day, while the death toll increased to 1,57,930 with 77 daily new fatalities, the data updated at 8 am showed.

Meanwhile, India has been at the forefront in fighting the coronavirus pandemic and "really stands out" in terms of its vaccine policy, Chief Economist of the IMF Gita Gopinath said on Monday, as she hailed the country for playing a very important role during the crisis by manufacturing and shipping the COVID-19 vaccines to several nation

Supply chain strain threatening Covid vaccine mass scale-up

The unprecedented scaling-up of vaccine manufacturing to counter Covid-19 has sparked dangerous shortages in the supply chain, global players acknowledged Tuesday after brainstorming how to speed up production of the jabs. Starting at zero when the pandemic began, vaccine manufacturers expect to be able to produce some 10 billion doses of various Covid-19 vaccines this year -- double the manufacturing capacity for all vaccines combined in 2019.
"This is the largest ramping up of manufacturing the world has ever seen," Thomas Cueni, the head of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), told a virtual press briefing. But the strain of this massive scale-up is beginning to show, Cueni acknowledged, after participating in a two-day online meeting on ways to unblock bottlenecks and rapidly boost vaccine production to combat the coronavirus that has killed 2.6 million people in 14 months.

Enjoyed this article? Stay informed by joining our newsletter!


You must be logged in to post a comment.

Related Articles
About Author